Diabetes Flashcards

1
Q

In simple terms, what is diabetes?

A

Diabetes mellitus is a condition associated with an elevated blood glucose.

This is a consequence of deficiency of INSULIN, or of its reduced action, or of a combination of both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is insulin? What role does it have in the body?

A

Insulin is the main hormone that regulates blood glucose – secreted by the pancreas – Beta cells in the islets of Langerhans

  • Anabolic hormone – hormone of storage
  • Essential for fuel storage and cell growth (mitotic action)
  • Promotes uptake of glucose into cells
  • Prevent breakdown of fat and protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where in the islets of langerhans are insulin producing cells located?

A

Predominant cell type – beta cells – manufacture and secrete insulin – located in centre

Alpha cells – produces glucagon – on the periphery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the role of somatostatin produced by delta cells in the pancreas?

A

Somatostatin – switches off synthesis and secretion of other hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of hormone is insulin? In what form is insulin synthesized?

A

Insulin is a peptide hormone

Synthesized as a pro-hormone – proinsulin – made of alpha and beta chain linked by a C-chain

Prior to release C-peptide is cleaved off by peptidases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain how glucose levels trigger insulin release by Beta-cells in the pancreas?

A

Secretion of insulin into portal circulation is directly coupled to the prevailing blood glucose level – secretion is tethered very closely to glucose levels

  1. Glucose enters the Beta cells via the Glut-2 transporters (don’t require action of insulin for import) – levels entering occurs in direct proportion to the level of glucose in the blood
  2. Glucose is then metabolized and processed by the TCA cycle producing large quantities of ATP
  3. ATP direct inhibits the opening of a potassium channel – channel closes - raises potassium levels in cell
  4. Causes membrane depolarization
  5. Opens a voltage gated Ca2+ channel – Ca2+ promotes the exocytosis of insulin molecules into circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is insulin release biphasic?

A

Prior to secretion Pro-insulin cleaved into insulin and C-peptide

Biphasic Response
1. In response to rising blood glucose – stored insulin will be released (already pre-made) - first wave.
2. Followed by increased production of newly synthesized insulin - second wave

C-peptide can be used as a measure of endogenous insulin secretion in people with diabetes that may be injecting exogenous insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Does insulin act on the liver or muscles/adipose tissue first?

A

INSULIN from pancreas:
1. Secreted into portal vein
2. Acts first on LIVER
3. Passes through liver into systemic circulation
4. Acts on MUSCLE and FAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the principle actions of insulin on the body?

A

Promotes
1. Liver - Increased glycogen storage
2. Muscle - Increased glucose uptake, glycogen storage, amino acid uptake and protein synthesis.
3. Fat - Increased glucose uptake and lipogenesis

Inhibits
1. Inhibits gluconeogenesis and ketogenesis
3. Inhibits apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In simple terms, how does insulin mediate its effect on cells?

A

Insulin binds to insulin receptor

Promotes one key final stage action – translocation of GLUT4 transporter to the plasma membrane – increasing glucose uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the different sources of glucose in the body?

A
  1. Diet
  2. Liver glycogen (used for blood glucose) and muscle glycogen (used for muscle)
  3. Liver and kidney can synthesize glucose from 3 carbon precursors - gluconeogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Does insulin favour gluconeogenesis/glycogenolysis or glycogenesis?

A

Liver plays a very important role – constant flux in terms of the formation/breakdown of glycogen and the formation of new glucose

Insulin favors the formation of glycogen and inhibition of gluconeogenesis – glucagon is the opposite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some other players that influence glucose homeostasis?

A

Glucose homeostasis is not only controlled by insulin.

Other hormones – adrenaline and noradrenaline, growth hormone, glucocorticoids – cortisol – promote an increase in blood glucose levels

Help protect against against hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why does glucose need to be tightly controlled?

A

In health blood glucose is maintained in very tight bands

Reason - required for the functioning of the brain as the brain has no glycogen, making it entirely dependent on blood glucose levels.

Therefore, it is important that we don’t go hypoglycemic

Other reasons…
* Maintenance of energy source for most tissues
* Integrity and health of blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do the words “Diabetes” “Mellitus” actually mean?

A

Diabetes mellitus
* Syphon – polyuria
* Mellitus – honey – sweet – excess glucose
* High urine output that is sweet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different types of diabetes (not just 1 and 2)?

A
  • Type 1
  • Type 2
  • Secondary Diabetes

Monogenic Diabetes
* MODY
* Diabetes & Syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

On a mechanistic level what are the two main causes of diabetes?

A
  1. Insulin Deficiency - Absolute deficiency occurs in the context of toxic insults to the islets (auto-immune insult, alcohol insult, or surgical insult)
  2. Insulin Resistance - more complicated interactions in signalling cascade in cells.

Or a combination of both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are examples of severe insulin resistance syndromes?

A

Specific insulin resistance syndromes that are related to specific gene defects - usually in the insulin receptor or very proximal downstream secondary messengers

Cause very profound insulin resistance – very rare

Dark pigmentation in axillae and skin folds – feature of severe insulin resistance

Examples…
* Leprechaunism
* Rabson-Mendenhall syndrome
* Type A insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What type of fat is associated with insulin resistance?

A

Central adiposity (visceral fat) – more common in men – associated with increasing levels of insulin resistance

Visceral fat is more metabolically active

Mechanism not fully understood by adipose tissue secretes various messengers/hormones - e.g. adipokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Apart from central obesity, what other conditions could increase insulin resistance?

A

Other causes of insulin resistance – GH, adrenaline and cortisol – impair the action of insulin – boost sugar levels

Pathogenic states of elevated GH, adrenaline and cortisol will cause insulin resistance such as…

  1. Acromegaly – GH overproduction
  2. Pheochromocytoma – tumour of the adrenals - increase adrenaline
  3. Cushing disease - increase cortisol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does the scale for fasting blood glucose look like - including normal, impaired fasting glycaemia and diabetes.

A

In epidemiological terms the ranges are defined when complications arise – specifically microvascular complications

Fasting glucose…
Below 6 - normal
Between 6-7 - pre-diabetic
Above 7 - diabetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the definitions of diabetes based on fasting blood glucose, 2hr Glucose following OGTT or random plasma glucose and HBa1c?

A
  1. Fasting plasma glucose – equal or greater than 7
  2. 2hr plasma glucose in Oral glucose tolerance test (OGTT) and random plasma glucose (unsure of fed state) – cut off at equal or greater than 11.1
  3. HbA1c – increasingly using glycated hemoglobin – greater or equal to 48 is considered diagnostic

If the patient is asymptomatic, the same test should be repeated to confirm the diagnosis of diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is HbA1c?

A

Measure of average glycemia – glucose will bind to hemoglobin in a directly proportional rate depending on ambient glucose concentrations

Average red blood cell has a life exp. of 120 days

Hence, HBA1c gives you an average of blood glucose over the last 3-4 months

Measured at any time of day independent of food consumption

Note - not only used as a diagnostic tool but also as a monitoring tool.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are situations when HbA1c should not be used in a diagnostic manner?

A
  1. Rapid onset of diabetes – not immediately translate into a rise in HbA1c - type 1, children and drug-induced – can not be used as a diagnostic!
  2. Pregnancy – glucose rise rapidly – HbA1c does not keep up
  3. Conditions where RBC survival decreases also impact HbA1c – disconnect between average glucose and HbA1c
  4. Conditions where RBC survival increases
  5. Renal dialysis
  6. Iron and vitamin B12 deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the oral glucose tolerance test?

A
  • Used to assess state of glucose tolerance
  • 75g oral glucose load
  • No restriction or modification of carbohydrate intake for preceding three days
  • Fast overnight
  • Test is performed in morning – seated; no smoking
  • Blood samples for plasma glucose taken at 0hrs and 2 hrs

Used in pregnancy or when HbA1c is not appropriate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How can we diagnose someone with impaired glucose tolerance or impaired fasting glucose?

A

Both considered pre-diabetic states

Impaired Glucose Tolerance
* Fasting Below 7 and OGTT 2 hour glucose value between 7.8-11.1

Impaired Fasting Glucose
* Fastign Plasma glucose - 6.0-6.9

Note - can also used HbA1c to identify pre-diabetic state - HbA1c 42-47

Increases risk of CVD and future diabetes

Can have a combination of impaired fasting glycemia and impaired glucose tolerance – even higher risk group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the most common type of diabetes?

A

Type 2 Diabetes
* Most common form of diabetes
* 85% of all diabetes in people of European heritage
* 95% of all diabetes in other ethnic groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are some risk factors for developing diabetes?

A
  • Genetics - Ethnicity (south asian, Polynesian and Arabic countries)
  • Increasing age - beta cell function decreases with age plus diabetes increases with age.
  • Central obesity - metabolic syndrome (HBP, high trigly, low HDL, etc.)
  • Low birth weight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Is there a strong genetic component to type 2 diabetes?

A

Genetic component is strong - 40% risk

Polygenic inheritance – multiple genes – over 400 different gene variants

Most relate to beta cell function or mass rather than obesity or insulin resistance (gene relating to this are present but less important)

Inherit a pancreas that functions less well – in practice if you gain weight and become insulin resistant your pancreas is less able to cope resulting in diabetes

Explains why people with a lower BMI (25-30) have diabetes and people with very high BMI that don’t have diabetes, where the pancreas is in overdrive

Type 2 diabetes – balance between beta-cell function and insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the different stages that lead us to type 2 diabetes?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the classical presenting features of type 2 diabetes?

A

Type 2 diabetes is commonly asymptomatic at diagnosis – people with risk factors are screened

Symptoms
* Osmotic symptoms - Thirst and polyuria
* Malaise and chronic fatigue
* Infections – hyperglycemia has an immunosuppressive effect and high glucose promotes germ growth – genital thrush, UTIs and skin/soft tissue infections all are more common
* Blurred vision – causes glycosylation of the lens of the eye – swelling of the lens – blurred vision
* Complication of diabetes – retinopathy or neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are examples of other medical disoders associated with type 2 diabetes?

A
  • Obstructive Sleep Apnoea
  • Polycystic Ovarian Disease
  • Hypogonadotrophic Hypogonadism in men
  • Non-Alcoholic Fatty Liver Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the symptoms on presentation for type 1 diabetes?

A
  • Osmotic symptoms - Polyuria and polydipsia
  • Fatigue and malaise
  • Weight loss – more common in type 1 (in type 2 it is possible on presentation) - because of insulin deficiency and osmotic diuresis weight loss is marked in type 1
  • Blurred vision
  • Nausea and vomiting
  • DKA can occur – life threatening – associated with nausea and vomiting on presentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How do type 1 diabetic patients normally present? What is the typical story?

A
  • Usual presentation is in childhood, adolescence or young adulthood
  • But can present at any age
  • Short history (weeks) of florid osmotic symptoms and rapid weight loss; Ketonuria/ketonaemia is usually present
  • High risk of metabolic decompensation - ketoacidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is the underlying pathogenesis behind type 1 diabetes?

A

Strong genetic element – HLA haplotypes as risk alleles – auto-immunity

Environmental trigger for the auto-immune process in genetically susceptible individuals (latency between trigger and onset) – thought to be viral and chemical

Activates an autoimmune process that destroys beta cells – measure auto-antibodies in the blood to GAD, IA2 and ZnT8 – these biomarkers are not pathogenic but rather a consequence of beta cell destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the stages of development for type 1 diabetes?

A

Stages of development

Normal individuals - inherited a polygenic susceptibility

  • Stage 1 – biomarkers are present – auto-antibodies – auto-immune process undergoing – inflammatory infiltrate in the islets – blood glucose remains normal
  • Stage 2 – progression of the auto-immune dysfunction – progressive deficiency of insulin – blood glucose levels are no longer normal – pre-diabetic
  • Stage 3 – islets destruction continues – stage 3 – symptomatic diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are other autoimmune disorders associated with type 1 diabetes?

A

Associated with other HLA mediated autoimmune disorders – Thyroid disease, pernicious anaemia, coeliac disease , Addison’s and vitiligo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How can type 1 diabetes imapct patients?

A
  1. Life-long treatment with insulin – risk of hypoglycemia – impacts on driving and employment – not allowed to drive heavy good vehicles, military deployment
  2. Risk of diabetic ketoacidosis
  3. Negative impact during pregnancy
  4. Impact on children and adolescence – difficulties with treatment
  5. Complications – increased risk of macrovascular complications but not to the same extent as type 2 – main complications are microvascular – more prevalent in type 1 because people are living with type 1 for 50,60 or 70 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is secondary diabetes?

A

Diabetes that arises/is secondary to other health conditions

40
Q

What examples of secondary diabetes do you need to know?

A
  1. Exocrine Pancreas Disorders - anything affecting the pancreas’s ability to function - pancreatitis (e.g. due to alcohol), cystic fibrosis, iron overload - hemochromatosis, trauma, tumour or surgery.
  2. Endocrinopathies - acromegaly, pheochromocytoma and cushings disease
  3. Drugs - Exogenous glucocorticoids - high dose of prednisolone/dexamethasone – higher risk of diabetes
41
Q

What is MODY?

A

Monogenic diabetes - Maturity-Onset Diabetes of the Young (MODY)

  • Early-onset diabetes
  • Not insulin-dependent diabetes - need type 2 diabetes medication for management.
  • Autosomal dominant inheritance - runs in families
  • Obesity unusual
  • Caused by a single gene defect altering beta-cell function
  • 1-2% of ‘Type 2’ diabetes
42
Q

What are examples of different genes affecting in MODYs?

A

Genes implicated in MODY – all have different phenotype

  • Glucokinase – leads to mild dysglycemia – can be exacerbated during pregnancy
  • Transcription factors - HNF1alpha – can be associated with cystic formation in the kidneys, early onset kidney failure and insulin requiring diabetes
  • Mitochondrial DNA mutations – associated with deafness – maternally inherited diabetes and deafness
  • MODY-X - genetic cause still unknown
43
Q

What are the differences/similarities between type 1 and 2 diabetes?

A

C-peptide – measure of endogenous insulin production – usually low in type 1 and high in type 2 – but differences can be present

44
Q

What are the three main microvascular complications associated with diabetes?

A
  1. Diabetic peripheral neuropathy
  2. Diabetic Nephropathy
  3. Diabetic Retinopathy - most common microvascular complication - can occur up to 7 years prior to diabetes diagnosis!
45
Q

What is the pathophysiology underlying microvascular complications?

A
  • Sugar alcohol accumulation has been linked to microaneurysm formation, thickening of basement membranes and loss of pericytes (cells that line blood vessels)
  • Cells are thought to be injured by glycoproteins
  • Oxidative stress may also play an important role in cellular injury from hyperglycaemia – free radical and ROS production
  • Growth factors including vascular endothelial growth factor (VEGF) and transforming growth factor B have also been postulated to have important roles
46
Q

How can we increase our ability to pick up on diabetic retinopathy?

A

Proactively screening using retinal photography

Usually asymptomatic especially in the earlier stages – important to pick up early

47
Q

How does hyperglycaemia lead to diabetic nephropathy?

A

Leading cause of end stage renal disease globally

  1. Initial constriction of the efferent arterioles and dilatation of the afferent
  2. Resultant glomerular pressure rises – resulting in hyperfiltration
  3. Gradually changes to hypotension through time
  4. Eventually we see glomerular filtration shutting off – glomerular filtration fails

Cellular changes…
* Thickening of basement membrane
* Widening of podocytes
* Increased mesangial cells

48
Q

How can we slow down the progression of nephropathy?

A
  • Good BP control
  • Improving glycaemic control
  • ACEI (reducing BP within the glomerular capillaries)

However if it continues we have to consider dialysis or transplantation as the kidney starts to fail.

49
Q

How does peripheral nepropathy lead to diabetic foot?

A
  • Peripheral neuropathy – lack of feeling in the feet
  • Neuropathic trauma – lack mechanisms of pain to alter behaviour
  • Infection/injury - ulcer becomes infected
  • Exacerbated by delayed wound healing – persistent trauma, infection, Ischaemia – delayed wound healing due to hyperglycaemia + peripheral vascular disease
50
Q

What are the main macrovascular complications associated with diabetes?

A
  1. Ischaemic Heart Disease
  2. Cerebrovascular Disease - acute (stroke or TIA) or chronic (vascular dementia)
  3. Peripheral Vascular Disease
51
Q

How does diabetes contribute to the formation of atherosclerosis?

A

Central pathological mechanism at play across all three macrovascular complications is atherosclerosis.

Disease process
1. Chronic inflammation and injury to the arterial wall - diabetes drives this process.
2. Accumulation of oxidized lipids from LDL particles in the injured endothelial wall
3. Monocytes infiltrate, differentiate into macrophages and phagocytose the lipids to form foam cells.
4. Inflammatory changes stimulate smooth muscle proliferation and collagen deposition.
5. Net result is the formation of a lipid rich atherosclerotic lesion with a fibrous cap.

52
Q

How does diabetes contribute to the risk of clot formation?

A

In addition to atheroma formation, people with type 2 diabetes show increased risk of clot formation

  1. Increased platelet adhesion
  2. Hypercoagulability

Mechanisms promoting platelet adhesion
* Impaired nitric oxide generation
* Increased free radical formation in platelets
* Altered calcium regulation

Futhermore…
* We see increased levels of plasminogen activator inhibitor type 1 - impairing fibrinolysis

Takeaway - Combination of INCREASED COAGULABILITY and IMPAIRED FIBRINOLYSIS - increases risk of vascular occlusion

53
Q

Diabetes complicaiton - what does peripheral vascular disease refer to?

A

Peripheral arterial disease – claudication (ischaemia of the limb) or poor wound healing (ulcers slow to heal)

Poor palpable pulses – indication of early peripheral vascular disease

54
Q

What are the four main acute emergencies associated with diabetes?

A
  1. Hypoglycaemia
  2. Diabetic Ketoacidosis
  3. Hyperosmolar Hyperglycaemic Syndrome (aka HONK)
  4. Lactic acidosis (Metformin)

These are listed in order of priority

55
Q

What is the most common diabetic emergency?

A

Hypoglycaemia

Most episodes treated at home

Average person with Type 1 DM will experience 1000s of episodes of mild hypoglycaemia

1-2 episodes of severe hypoglycaemia every year

Severe Hypo - need for external assistance

Exclude in any unconscious or fitting patient (ABC.. ….DEFG: Don’t Ever Forget Glucose)

56
Q

What is the most common cause of hypoglycemia?

A

Insulin use!

  1. Patient error – too much insulin, too little carbs, miss/late meal and exercise
  2. Alcohol

Same applies for patients on sulphonylureas (stimulate insulin release by beta cells) eg gliclazide, glipizide

57
Q

What is the mechanism underlying sulphonylureas (e.g. glicazide)?

A
  1. Gliclazide selectively binds to sulfonylurea receptors (SUR-1) on the surface of the pancreatic beta-cells.
  2. This binding effectively closes these K+ion channels.
  3. This decreases the efflux of potassium from the cell which leads to the depolarization of the cell.
  4. This causes voltage dependent Ca2+ion channels to open increasing the Ca2+influx.
  5. The raise in calcium ultimately leads to exocytosis of insulin vesicles leading to insulin release
58
Q

What are some other causes of hypoglycemia?

A
59
Q

Outline the mechanisms the body uses to prevent hypoglycemic episodes?

A

Be aware of the conter-regulation

  1. Pancreas decreases insulin production and produces glucagon instead from alpha cells – tells liver to release more glucose (break down glycogen and gluconeogenesis)
  2. Adrenal glands – release epinephrine – signals to the liver and kidneys to produce more glucose + also prevent muscles from up taking too much glucose and acts to reduce insulin secretion
  3. If body fails to increase blood glucose – body releases cortisol and GH – attempts to increase blood glucose
60
Q

At what blood glucose level is endogenous insulin secretion inhibited? What point to other mechanisms kick in?

A

Lower than 4 – inhibition of endogenous insulin

Thereafter – counterregulatory hormones – glucagon and adrenaline are released

61
Q

What are the symptoms of a hypoglycemic epsiode?

A
  • These are most common symptoms in young adults
  • Children often manifest behavioural change
  • Elderly can have neurological symptoms (eg mimic stroke)
  • Symptoms are idiosyncratic and may change with time
62
Q

What happens to the counterregulatory responses the longer someone lives with diabetes?

A

Counterregulatory hormones decrease with increasing duration of diabetes

Important to be aware of as it helps to explain why people lose their hypoglycemic awareness - counterregulatory mechanisms are important in telling us that we are in a hypo state (e.g. adrenaline stimulates an autonomic response)

So if counterregulatory mechanisms kick in later, we potentially only become aware of our hypoglycemic at a later stage.

Forms a vicious cycle were lack of awareness drives more hypoglycemic episodes which increase our lack of awareness.

63
Q

How is hypoglycemia diagnosed?

A

Whipple’s triad: 2 out of 3 of-
1. Typical symptoms
2. Biochemical confirmation (no agreed cut-off)
3. Symptoms resolve with carbohydrate

Remember ‘atypical’ presentations esp in elderly - Hemiparesis

In theory, confirm with laboratory blood glucose – but don’t delay treatment

64
Q

What is the management for hypoglycemia?

A

Management of hypoglycemia – depends on alertness and swallowing safety
- If alert – give sweet drink or dextrose tablet
- If not alert – give 20% iv dextrose
- If no IV access Glucagon intra-muscularly – not effectively in alcoholic hypo

Follow up with slow release carbs after immediate hypo is treated

If recovery is not rapid – consider other cause

Full cognitive recovery can lag by 45 mins

65
Q

What is the aftercare for after a hypoglycemic episode?

A
  1. After the initial treatment – important to follow up the patient with complex carbohydrates – sustained glucose available – prevents immediate relapse
  2. Patients presenting to hospital - discharge patients if they have made a full recovery and if there is a responsible adult at home who can monitor – considered more carefully with it was sulfonylurea induced
  3. Inform the diabetes team
  4. Close monitoring of blood glucose for next 72 hours
  5. Was there an obvious remedial cause? - If not, cut right back on insulin doses
66
Q

What is continious glucose monitoring?

A

Blood glucose sensor is attached to the patient (e.g. abdomen) – provides second by second glucose readings - helps to prevent hypos

In some cases can provide feedback to insulin pump

67
Q

What are some practical driving considerations for drivers with insulin-treated diabetes?

A

Driver should…
1. Carry glucose monitor
2. Carry rescue carbohydrates
3. Check glucose before driving
4. Test every 2 hours on long journeys – taking regular snacks
5. If glucose less than 5 – take snack
6. Less than 4 – do not drive
7. Carry ID saying you have diabetes in case of an accident

If you have a hypo while driving…
* Stop vehicle as soon as safe
* Switch off engine and remove keys from ignition
* Get out of driver’s seat
* Wait 45 mins after blood glc normal before driving

68
Q

Do patients with hypos need to inform the DVLA?

A

Drivers must inform DVLA if:
* >1 severe hypo whilst awake within last yr (need for assistance)
* If you or your carer feel you are at high risk of developing hypo
* Develop impaired hypo awareness
* Suffer hypo while driving

69
Q

What are the two types of hyperglycemic emergency? Who do they usually affect?

A

Hyperglycemic Emergencies

  • Diabetic ketoacidosis develops in type 1 DM (or longstanding type 2 with insulin deficiency)
  • In type 2 diabetes, it is more usual to develop a hyperosmolar hyperglycaemic state - large amounts of diuresis resulting in hypovolemia – as a consequence of hyperglycaemia for a prolonged period time
70
Q

Outline the pathogenesis underlying DKAs?

A
  1. Lack of insulin – unable to utilize glucose
  2. Leads to glucose accumulation in the blood causing hyperglycemia
  3. Leads to FFA mobilization – lipolysis
  4. Leads to ketone body production – energy source – acetone, 3-beta-hydroxy-butyrate (main) and aceto-acetate
  5. Leading to ketonemia – ketone bodies are weak acids – but if levels increase – leads to metabolic acidosis & Ketonuria
  6. Raised glucose levels leads to osmotic diuresis and profound hypovolemia – exacerbated by vomiting – lead electrolyte derangement, LOC and death
71
Q

Outline the pathogenesis of hyperosmolar hyperglycaemic syndrome?

A
  1. Inability to use blood glucose
  2. Leads to excess levels of glucagon
  3. Resulting in increased glycogenolysis and gluconeogenesis (e.g. from muscle proteinolysis)
  4. Raises serum glucose even further
  5. Drives osmotic diuresis and hypovolemia
  6. Due to hypovolemia we see a drop in the GFR (renal impairment) which drives up glucose levels further
  7. Ultimately resulting in electrolyte derangement, LOC and death
72
Q

How is DKA managed?

A

Principle management
1. Fluids – fast and then slower to rehydrate
2. Given IV insulin to switch off ketone production (glucose might need to be provided later to compensate)
3. Monitor potassium – metabolic acidosis shifts to the extracellular space – will shift back into cells with treatment resulting in K+ fall
4. Look for the precipitant – e.g. infection or errors/omissions but often a cause is not found

73
Q

What symptoms are associated with DKA?

A

DKA symptoms:
1. Polyuria, polydipsia
2. Hypovolemia – low JVP, low BP, high HR, electrolyte deficit
3. Abdominal pain and nausea + vomiting
4. Kussmaul respiration/ketotic breath – expire CO2
5. Muscle cramps

74
Q

Things to consider in DKA aftercare after acute management?

A
  • Swap to subcutaneous insulin once patient is eating/drinking
  • Ensure basal insulin is given 1 bour before IV insulin is stopped – prevent rebound
  • Identify precipitant
  • Don’t miss the opportunity for patient education
  • Look out for any complications
75
Q

How is a diagnosis for HHS performed?

A

Usual finding is MARKED hyperglycaemia, raised osmolality and mild/no ketoacidosis

DIAGNOSIS
1. Hyperglycaemia (>30mmol/l, but often 60-90 mmol/l))
2. Serum osmolality >320mmol/Kg
3. No / mild ketoacidosis
4. Severe dehydration and pre-renal failure common

76
Q

How does HHS normally present?

A

In absence of ketosis, patients don’t feel sick so take longer to come to medical attention.

  • Insidious onset
  • Profound dehydration (9-10L deficit)
  • Hypercoagulability (exclude CVA, DVT, PE)
  • Confusion, coma, fits.
  • Gastroparesis, N&V, haematemesis
77
Q

What is the management for HHS?

A

Management similar to DKA (protocols) but:
* Slower, prolonged rehydration
* Gradual reduction in Na+
* Gentler glucose reduction
* Anticoagulation vital: Prophylactic sc heparin
* Seek the precipitant (infection, MI etc)

78
Q

What are some safety consideration when using metformin?

A

MF use may exacerbate lactic acidosis when tissue hypoxia is present - no the trigger itself

Things to consider
* Metformin is cleared from the kidneys – if kidney function impaired (GFR less than 30 or worsening fast) – stop metformin
* People that come in that are acutely unwell (Shock, MI, sepsis, dehydration and acute renal failure) – stop metformin temporarily until the acute illness resolves
* Withdraw metformin when providing iodine-containing contract or anesthetic use

79
Q

How do these variables differs between type 1 and 2 diabetes?

A
80
Q

How do the symptoms between type 1 and 2 diabetes differ? What diagnostic test(s) is used for both?

A
81
Q

Can HbA1c levels be normal in a type 1 diabetic patient?

A

Yes, may be normal in T1DM diagnosis due to acute onset

82
Q

Is hypoglycemia a feature of diabetes mellitus?

A

Not strictly a feature of DM but rather a side effect of some medications –insulin or sulphonylurea

83
Q

How can be prevent the occurence of macrovascular and microvascular complications in diabetics?

A

Improving blood sugar control/levels!

84
Q

What are the different drugs that are used for treating type 2 diabetes? Which ones are 1st, 2nd and 3rd line?

A

Important to forget that technically first line is diet and exercise for 6 months (variable)!

First line - Metformin
Second Line - Sulphonylureas
Third line - Thiazolidinediones/Glitazones

Other popular drugs…
* Incretin mimics (satiety, increase insulin release and inhibit glucagon release) - also help with weight management
* SGLT-2 inhibitors - also help with kidney and CVD

85
Q

How do the main groups of drugs for type 2 diabetes influence the liklihood of hypoglycemia and weight? What are other side effects to remember?

A
86
Q

What are the key principles of type 2 diabetes management?

A
  1. Reduce blood glucose levels - lifestyle and medication
  2. Blood Pressure control
  3. Manage lipid profile and urine albumion:creatinine ratio
87
Q

What are vascular, neurological, drugs/substances, psychological and endocrine causes of erectile dysfunction?

A
88
Q

What are potential treatments for erectile dysfunction?

A
89
Q

Is one random glucose reading >11.1 in a asymptomatic patient diagnostic?

A

No, one abnromal reading in an asymptomatic patient is not diagnostic

Need to look at fasting glucose, OGTT or HbA1c

90
Q

Is one random glucose reading >11.1 in a symptomatic patient diagnostic?

A

Yes, abnormal reading plus symptomatic - diagnostic

91
Q

Do you need to inform the DVLA if you have a diabetes diagnosis?

A

You must tell the DVLA if you’re diabetes is treated with insulin or some specific medications (e.g. sulphonylureas).

92
Q

How is diabetic retinopathy screened and prevented?

A
  • Retinal screening programme
  • Control glucose
  • Control BP
  • Extra - laser treatment, anti-VEGF injections.
93
Q

How is diabetic nephropahty screened and prevented?

A

Glucose control as primary prevention

Look at/consider…
* ACR/PCR
* eGFR
* Manage BP - use of ACEI

94
Q

What are the main players that increase or decrease glucose?

A
95
Q

How do we screen for microvascular complications?

A

Retinopathy screening
* At least 2 yearly by retinal photography
* 6-monthly at PAEP in some cases for higher risk

Urinary ACR annually

Annual foot examination

96
Q

What are the different insulin regimes that can be used in the treatment of type 1 diabetes?

A

BASAL-BOLUS (multiple daily injection): Usually fast-acting insulin before meals with long-acting insulin once daily

TWICE DAILY: Usually fixed mixture of fast-acting and intermediate-acting insulin

ONCE DAILY: Usually long-acting insulin, combined with anti-diabetic drugs (Type 2 diabetes)

CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (only TYPE 1): fast-acting insulin delivered continuously to cover basal requirements and before meals to cover food intake. Can be combined with continuous glucose monitoring in a hybrid closed loop system